The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension

Por Viswanathan, Gayathri, Mamazhakypov, Argen, Schermuly, Ralph T., Rajagopal, Sudarshan
Publicado no Front Cardiovasc Med (2018)

Molecular mechanisms of hypoxia‐inducible factor‐induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension

Por Veith, Christine, Schermuly, Ralph T., Brandes, Ralf P., Weissmann, Norbert
Publicado no J Physiol (2015)

Mechanisms of disease: pulmonary arterial hypertension

Por Schermuly, Ralph T., Ghofrani, Hossein A., Wilkins, Martin R., Grimminger, Friedrich
Publicado no Nat Rev Cardiol (2011)

Cardioprotection in right heart failure

Por Boengler, Kerstin, Schlüter, Klaus‐Dieter, Schermuly, Ralph Theo, Schulz, Rainer
Publicado no Br J Pharmacol (2020)

Genetic Delivery and Gene Therapy in Pulmonary Hypertension

Por Rai, Nabham, Shihan, Mazen, Seeger, Werner, Schermuly, Ralph T., Novoyatleva, Tatyana
Publicado no Int J Mol Sci (2021)

Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature

Por Maarman, Gerald J, Schulz, Rainer, Sliwa, Karen, Schermuly, Ralph Theo, Lecour, Sandrine
Publicado no Br J Pharmacol (2017)

Effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculation in endotoxinemic rats

Por Mihaylova, Stanka, Killian, Anke, Mayer, Konstantin, Pullamsetti, Soni Savai, Schermuly, Ralph, Rosengarten, Bernhard
Publicado em 2012

Natural plant products in treatment of pulmonary arterial hypertension

Por Xiang, Lili, Li, Ying, Deng, Xu, Kosanovic, Djuro, Schermuly, Ralph Theo, Li, Xiaohui
Publicado no Pulm Circ (2018)

Relevance of angiopoietin-2 and soluble P-selectin levels in patients with pulmonary arterial hypertension receiving combination therapy with oral treprostinil: a FREEDOM-C2 biomar...

Por Richter, Manuel J., Schermuly, Ralph, Seeger, Werner, Rao, Youlan, Ghofrani, Hossein A., Gall, Henning
Publicado no Pulm Circ (2016)

Enhanced inflammatory cell profiles in schistosomiasis-induced pulmonary vascular remodeling

Por Ali, Zahara, Kosanovic, Djuro, Kolosionek, Ewa, Schermuly, Ralph T., Graham, Brian B., Mathie, Alistair, Butrous, Ghazwan
Publicado no Pulm Circ (2017)

Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis

Por Sajjad, Amna, Novoyatleva, Tatyana, Vergarajauregui, Silvia, Troidl, Christian, Schermuly, Ralph T, Tucker, Haley O., Engel, Felix B
Publicado em 2014

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension

Por Kojonazarov, Baktybek, Hadzic, Stefan, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Seeger, Werner, Weissmann, Norbert, Schermuly, Ralph Theo
Publicado no Am J Respir Crit Care Med (2019)

Acute effects of phosphodiesterase 5 (PDE5) inhibition, ANP and NO on epididymal contractility are preserved despite chronic PDE5 exposure

Por Mietens, Andrea, Feuerstacke, Caroline, Tasch, Sabine, Eichner, Gerrit, Schermuly, Ralph Theo, Grimminger, Friedrich, Müller, Dieter, Middendorff, Ralf
Publicado em 2011

Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers

Por Sydykov, Akylbek, Mamazhakypov, Argen, Petrovic, Aleksandar, Kosanovic, Djuro, Sarybaev, Akpay S., Weissmann, Norbert, Ghofrani, Hossein A., Schermuly, Ralph T.
Publicado no Front Physiol (2018)

Profiling of human lymphocytes reveals a specific network of protein kinases modulated by endurance training status

Por Alack, Katharina, Weiss, Astrid, Krüger, Karsten, Höret, Mona, Schermuly, Ralph, Frech, Torsten, Eggert, Martin, Mooren, Frank-Christoph
Publicado no Sci Rep (2020)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors

Por Schermuly, Ralph Theo, Inholte, Christiane, Ghofrani, Hossein Ardeschir, Gall, Henning, Weissmann, Norbert, Weidenbach, Andreas, Seeger, Werner, Grimminger, Friedrich
Publicado em 2005

Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition

Por Keserü, Benjamin, Barbosa-Sicard, Eduardo, Schermuly, Ralph T., Tanaka, Hiromasa, Hammock, Bruce D., Weissmann, Norbert, Fisslthaler, Beate, Fleming, Ingrid
Publicado em 2010

sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung

Por Egemnazarov, Bakytbek, Sydykov, Akylbek, Schermuly, Ralph T, Weissmann, Norbert, Stasch, Johannes-Peter, Seeger, Werner, Grimminger, Friedrich, Ghofrani, Hossain A
Publicado em 2009

Effects of riociguat in severe experimental pulmonary hypertension

Por Kojonazarov, Baktybek, Lang, Michaela, Weissmann, Norbert, Grimminger, Friedrich, Stasch, Johannes-Peter, Seeger, Werner, Ghofrani, Hossein Ardeschir, Schermuly, Ralph
Publicado em 2011

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats

Por Lang, Michaela, Kojonazarov, Baktybek, Weissmann, Norbert, Grimminger, Friedrich, Stasch, Johannes-Peter, Seeger, Werner, Ghofrani, Hossein Ardeschir, Schermuly, Ralph
Publicado em 2011